[Comment] Making sense of consensus: comparative modelling of malaria interventions

The following two tabs change content below.
Lancet Global Health
The Lancet Global Health is The Lancet's first gold open-access title and focuses on original research, commentary, correspondence and blogs on topics including maternal and child health, infectious and noncommunicable diseases, mental health, and more. The Editor is Zoë Mullan.

Although the global burden of malaria has been greatly reduced through, for example, vector control,1 the disease is still a major concern and there is renewed interest in mass drug administration (MDA) as an additional control intervention. A Cochrane review2 of MDA for malaria, which included 32 studies, concluded that MDA substantially reduces the risk of infection leading to malaria. However, this study also raised the concern that these reductions are often not sustained. Another review from 20153 suggested that, although MDA is successful in controlling and eliminating disease, there remain substantial knowledge gaps and further studies are essential, particularly on optimal size of the target population, methods to improve coverage, and drug safety.

Original article: 

[Comment] Making sense of consensus: comparative modelling of malaria interventions